Biofrontera Inc (BFRI) Stock Analysis

Biofrontera Inc (BFRI) is a publicly traded company in the HEALTHCARE sector. It trades at $1.03, carries a market capitalization of $11.33M. This page summarizes the public market data, fundamentals, and frequently asked questions for BFRI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $1.03
• Market Cap: $11.33M
• EPS: $-0.98
• 52-Week High: $1.19
• 52-Week Low: $0.56

Market Sentiment

Biofrontera Inc currently has a Bullish sentiment score of 0.23.

About Biofrontera Inc

Biofrontera Inc. is a biopharmaceutical company headquartered in Woburn, Massachusetts, specializing in the development and commercialization of innovative dermatological therapies for various skin conditions. By leveraging its proprietary technologies, Biofrontera strives to enhance treatment efficacy and patient outcomes in the U.S. dermatology market. The company is committed to improving dermatological care and is actively expanding its product portfolio to solidify its position as a key ...

GNG Research Analysis

GNG Research scores Biofrontera Inc (BFRI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BFRI.

Frequently Asked Questions

Does BFRI pay dividends?

Biofrontera Inc (BFRI) does not currently pay a regular dividend.

What is BFRI's market cap?

Biofrontera Inc (BFRI) has a market capitalization of $11.33M with a current stock price of $1.03.